128 related articles for article (PubMed ID: 27074525)
1. Antibodies against angiotensin II type 1 receptor (AT1R) and endothelin receptor type A (ETAR) in systemic sclerosis (SSc)-response.
Riemekasten G; Cabral-Marques O
Autoimmun Rev; 2016 Sep; 15(9):935. PubMed ID: 27074525
[No Abstract] [Full Text] [Related]
2. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
[TBL] [Abstract][Full Text] [Related]
3. Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis.
Cabral-Marques O; Riemekasten G
Autoimmun Rev; 2016 Jul; 15(7):690-4. PubMed ID: 26970493
[TBL] [Abstract][Full Text] [Related]
4. Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18.
Rademacher J; Kill A; Mattat K; Dragun D; Siegert E; Günther J; Riemekasten G
J Rheumatol; 2016 Mar; 43(3):587-91. PubMed ID: 26773103
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies.
Civieri G; Iop L; Tona F
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055116
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.
Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528
[TBL] [Abstract][Full Text] [Related]
7. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
8. Agonistic antibodies in systemic sclerosis.
Moroncini G; Svegliati Baroni S; Gabrielli A
Immunol Lett; 2018 Mar; 195():83-87. PubMed ID: 29032187
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.
Avouac J; Riemekasten G; Meune C; Ruiz B; Kahan A; Allanore Y
J Rheumatol; 2015 Oct; 42(10):1801-7. PubMed ID: 26233500
[TBL] [Abstract][Full Text] [Related]
10. Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Zmonarski S; Mazanowska O; Krajewska M; Bartoszek D; Zabińska M; Myszka M; Kamińska M; Hałoń A; Dawiskiba T; Szyber P; Sas A; Klinger M
Transplant Proc; 2014 Oct; 46(8):2618-21. PubMed ID: 25380879
[TBL] [Abstract][Full Text] [Related]
11. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis.
Binda M; Moccaldi B; Civieri G; Cuberli A; Doria A; Tona F; Zanatta E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396976
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients.
Miedema JR; Janssen ML; von der Thüsen J; Endeman H; Langerak AW; Hellemons ME; van Nood E; Peeters BWA; Baart SJ; Schreurs MWJ
Front Immunol; 2023; 14():1204433. PubMed ID: 37622126
[TBL] [Abstract][Full Text] [Related]
14. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course.
Miedema J; Schreurs M; van der Sar-van der Brugge S; Paats M; Baart S; Bakker M; Hoek R; Dik WA; Endeman H; Van Der Velden V; van Gammeren A; Ermens A; Aerts JG; Thüsen JV
Front Immunol; 2021; 12():684142. PubMed ID: 34054876
[TBL] [Abstract][Full Text] [Related]
15. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
Reinsmoen NL; Mirocha J; Ensor CR; Marrari M; Chaux G; Levine DJ; Zhang X; Zeevi A
Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiotensin II type 1 receptor autoantibodies (AT
İlgen U; Yayla ME; Düzgün N
Rheumatol Int; 2017 Apr; 37(4):593-598. PubMed ID: 28004166
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune activation and hypersensitization of the AT1 and ETA receptors contributes to vascular injury in scleroderma renal crisis.
Hegner B; Kretzschmar T; Zhu N; Kleinau G; Zhao H; Kamhieh-Milz J; Hilger J; Schindler R; Scheerer P; Riemekasten G; Philippe A; Catar R
Rheumatology (Oxford); 2023 Jun; 62(6):2284-2293. PubMed ID: 36227102
[TBL] [Abstract][Full Text] [Related]
18. When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis.
Akbarzadeh R; Müller A; Humrich JY; Riemekasten G
Front Immunol; 2023; 14():1213804. PubMed ID: 37359516
[TBL] [Abstract][Full Text] [Related]
19. Functional autoantibodies in systemic sclerosis pathogenesis.
Kill A; Riemekasten G
Curr Rheumatol Rep; 2015 May; 17(5):34. PubMed ID: 25876754
[TBL] [Abstract][Full Text] [Related]
20. Effect of electroacupuncture stimulation on expression of angiotensinogen, angiotensin II type 1 receptor, endothelin-1, and endothelin a receptor mRNA in spontaneously hypertensive rat aorta.
Huo ZJ; Li D; Guo J; Li S; Ding N; Li ZX
Chin J Integr Med; 2016 Oct; 22(10):778-82. PubMed ID: 27412588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
